IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·IPUBLIC RECORDSEXCHANGERECEIPTSloadinglive·IMONEY TRAILEXCHANGESOURCESverifyinglive·IDATA SOURCESEXCHANGEFILINGSpublic recordslive·
← Ticker index
AMED
Ticker

AMED

Congressional Trades
6
by 1 members
Ticker disclosure brief

Congressional disclosure records for AMED

A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.

Latest receipt
Lisa McClain
SELL · 2025-08-18
Largest range
$1K – $15K
Lisa McClain
Longest observed gap
66d
Lisa McClain
Highest 30d vs SPY
-0.4%
Lisa McClain
Purchase rows
3
50%
Sale rows
3
50%
Disclosed midpoint
$48K
range estimate
Unique Traders
1
members
Disclosure timing method

Observed filing gaps are not notice-date findings

The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.

Party Breakdown

Democrats0 · 0%
Republicans6 · 100%

Lobbying filings

all →
  • 2026-04-20$30K
    AMEDISYS INC.
    Strategic guidance and counsel on home health reimbursement and policy including The Preserving Access to Home Health Act (S. 4605/ H.R. 8581)
  • 2026-01-20$30K
    AMEDISYS INC.
    Strategic guidance and counsel on home health reimbursement and policy including The Preserving Access to Home Health Act (S. 4605/ H.R. 8581)
  • 2025-10-20$30K
    AMEDISYS INC.
    Strategic guidance and counsel on home health reimbursement and policy including The Preserving Access to Home Health Act (S. 4605/ H.R. 8581)
  • 2025-07-21$30K
    AMEDISYS INC.
    Strategic guidance and counsel on home health reimbursement and policy including The Preserving Access to Home Health Act (S. 4605/ H.R. 8581)
  • 2025-04-21$410K
    AMEDISYS INC.
    Issues related to home health and hospice payment policies and funding, program integrity matters and quality metrics, continuation of hospital-at-home; Issues related to healthcare workforce matters
  • 2025-04-21$90K
    AMEDISYS INC.
    Strategic guidance and counsel on home health reimbursement and policy including The Preserving Access to Home Health Act of 2022 (S. 4605/ H.R. 8581)
  • 2025-03-31$50K
    AMEDISYS HOME HEALTH AND HOSPICE CARE
  • 2025-01-21$80K
    AMEDISYS HOME HEALTH AND HOSPICE CARE
    Payment issues related to Medicare Home Health benefit; S. 2137/H.R. 5159, Preserving Access to Home Health Act; CMS-1803-P, or the CY 2025 Home Health Prospective Payment System Rate Update; H.R. 9803, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act; H.R. 10545, American Relief Act, 2025
  • 2025-01-20$120K
    AMEDISYS INC.
    Strategic guidance and counsel on home health reimbursement and policy including The Preserving Access to Home Health Act of 2022 (S. 4605/ H.R. 8581)
Loading trade analytics…

All Disclosed Trades

Page 1 · 6 of 6 shown
DateMemberActionAmountObserved GapReceipt
2025-08-18RLisa McClainSELL$1K – $15K28dreceipt →
2025-08-18RLisa McClainSELL$1K – $15K25dreceipt →
2025-08-18RLisa McClainSELL$1K – $15K25dreceipt →
2025-06-09RLisa McClainBUY$1K – $15K66dApparent delayreceipt →
2025-06-09RLisa McClainBUY$1K – $15K65dApparent delayreceipt →
2025-06-09RLisa McClainBUY$1K – $15K65dApparent delayreceipt →

“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.